Sabra Healthcare REIT (NASDAQ:SBRA) Given New $21.00 Price Target at UBS Group

Sabra Healthcare REIT (NASDAQ:SBRA) had its price target trimmed by UBS Group from $22.00 to $21.00 in a research note released on Wednesday,Benzinga reports. The brokerage currently has a neutral rating on the real estate investment trust’s stock.

Other equities analysts also recently issued research reports about the company. Weiss Ratings downgraded Sabra Healthcare REIT from a “buy (b+)” rating to a “buy (b)” rating in a research report on Thursday, June 4th. Cantor Fitzgerald lifted their price objective on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “neutral” rating in a report on Monday, May 11th. Scotiabank cut their price objective on shares of Sabra Healthcare REIT from $22.00 to $19.00 and set a “sector perform” rating on the stock in a research report on Thursday, June 18th. Truist Financial restated a “buy” rating and set a $22.00 target price on shares of Sabra Healthcare REIT in a report on Wednesday. Finally, Citigroup downgraded shares of Sabra Healthcare REIT from a “buy” rating to a “neutral” rating and decreased their target price for the company from $24.00 to $19.00 in a research report on Monday, June 22nd. Five research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, Sabra Healthcare REIT currently has a consensus rating of “Hold” and a consensus target price of $21.45.

Sabra Healthcare REIT Stock Down 0.1%

Shares of NASDAQ:SBRA opened at $20.03 on Wednesday. Sabra Healthcare REIT has a 52 week low of $17.17 and a 52 week high of $21.28. The company has a debt-to-equity ratio of 0.96, a quick ratio of 4.72 and a current ratio of 4.72. The company has a market capitalization of $5.05 billion, a PE ratio of 31.79, a PEG ratio of 1.50 and a beta of 0.65. The company has a 50 day moving average price of $19.70 and a two-hundred day moving average price of $19.69.

Sabra Healthcare REIT (NASDAQ:SBRA) last released its quarterly earnings results on Wednesday, April 29th. The real estate investment trust reported $0.16 EPS for the quarter, hitting analysts’ consensus estimates of $0.16. The company had revenue of $211.74 million for the quarter, compared to analyst estimates of $209.20 million. Sabra Healthcare REIT had a return on equity of 5.60% and a net margin of 19.22%.Sabra Healthcare REIT’s revenue was up 20.9% compared to the same quarter last year. During the same quarter last year, the firm posted $0.37 earnings per share. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. Analysts forecast that Sabra Healthcare REIT will post 1.5 earnings per share for the current year.

Sabra Healthcare REIT Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, May 29th. Shareholders of record on Friday, May 15th were issued a $0.30 dividend. This represents a $1.20 annualized dividend and a yield of 6.0%. The ex-dividend date of this dividend was Friday, May 15th. Sabra Healthcare REIT’s dividend payout ratio is currently 190.48%.

Institutional Investors Weigh In On Sabra Healthcare REIT

A number of hedge funds and other institutional investors have recently modified their holdings of SBRA. Rothschild Investment LLC boosted its holdings in Sabra Healthcare REIT by 164.6% in the 4th quarter. Rothschild Investment LLC now owns 1,429 shares of the real estate investment trust’s stock valued at $27,000 after purchasing an additional 889 shares during the period. Smartleaf Asset Management LLC grew its position in shares of Sabra Healthcare REIT by 97.7% during the 4th quarter. Smartleaf Asset Management LLC now owns 1,445 shares of the real estate investment trust’s stock worth $27,000 after purchasing an additional 714 shares in the last quarter. Versant Capital Management Inc increased its holdings in shares of Sabra Healthcare REIT by 70.0% during the second quarter. Versant Capital Management Inc now owns 1,465 shares of the real estate investment trust’s stock worth $29,000 after purchasing an additional 603 shares during the period. Founders Capital Management bought a new position in shares of Sabra Healthcare REIT during the third quarter worth approximately $28,000. Finally, Strengthening Families & Communities LLC acquired a new stake in shares of Sabra Healthcare REIT in the fourth quarter valued at approximately $29,000. Institutional investors and hedge funds own 99.40% of the company’s stock.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.